Pharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in mice

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 2, 2005, Pages 177-181

  Shimada, Tsutomu ^a   Nomura, Masaaki ^a   Yokogawa, Koichi ^a   Endo, Yoshio ^b   Sasaki, Takuma ^b   Miyamoto, Ken Ichi ^a   Yonemura, Yutaka ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; ASCITES FLUID LEVEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; FEMALE; INTESTINE; KIDNEY PARENCHYMA; LIVER; MOUSE; NONHUMAN; PERITONEUM METASTASIS; SPLEEN; STOMACH CANCER; TOXICITY;

ANIMALS; AREA UNDER CURVE; ASCITIC FLUID; CELL LINE, TUMOR; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INTESTINES; JAPAN; LIVER; MICE; MICE, INBRED ICR; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PERITONEAL CAVITY; PERITONEAL NEOPLASMS; SPLEEN; TAXOIDS; TIME FACTORS;

EID: 12344302007     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357055380     Document Type: Article

References (16)

1. Alberts, D. S., Liu, P. Y., Hannigan, E. V., O'Toole, R., Williams, S. D., Young, J. A., Franklin, E. W., Clarke-Pearson, D. L., Malviya, V. K., DuBeshter, B. (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N. Engl. J. Med. 335: 1950-1955
2. Diaz, J. F., Andreu, J. M. (1993) Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition. Biochemistry 32:2747-2755
3. Dykes, D. J., Bissery, M. C., Harrison, S. D., Waud, W. R. (1995) Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere). Invest. New Drugs 13: 1-11
4. de Bree, E., Romanos, J., Michalakis, J., Relakis, K., Georgoulias, V., Melissas, J., Tsiftsis, D. D. (2003) Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin. Anticancer Res. 23: 3019-3027
5. Furui, N., Yamazaki, T., Yokogawa, K., Fushida, Y., Miwa, K., Miyamoto, K. (2003) Ascites and the plasma concentration-time courses of the taxanes after an intraperitoneal administration in patients with peritoneal tumors. Jpn. J. Health Care Sci. 29: 263-269
6. Fushida, S., Nao, F., Kinami, S., Ninomiya, I., Fujimura, T., Nishimura, G., Ohta, T., Yokogawa, K., Miyamoto, K., Miwa, K. (2002a) Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination. Jpn. J. Cancer Chemother. 29: 1759-1763
7. Fushida, S., Nao, F., Kinami, S., Ninomiya, I., Fujimura, T., Nishimura, G., Ohta, T., Yokogawa, K., Miyamoto, K., Miwa, K. (2002b) Pharmacologic study of intraperitoneal paclitaxel in gastric cancer patients with peritoneal dissemination. Jpn. J. Cancer Chemother. 29: 2164-2167
8. Jacquet, P., Sugarbaker, P. H. (1996) Peritoneal-plasma barrier. Cancer Treat. Res. 82: 53-63
9. Loos, W. J., Verweij, J., Nooter, K., Stoter, G., Sparreboom, A. (1997) Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography. J. Chromatogr. B: Biomed. Sci. Appl. 693: 437-441
10. Marchettini, P., Stuart, O. A., Mohamed, F., Yoo, D., Sugarbaker, P. H. (2002) Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model. Cancer Chemother. Pharmacol. 49: 499-503
11. Maruyama, M., Ebuchi, M., Nagahama, T., Takashima, I., Hasegawa, K. (2003) Experimental study on intraperitoneal versus intravenous paclitaxel for peritoneal seeding and liver metastasis. Jpn. J. Cancer Chemother. 30: 1602-1604
12. Morgan, R. J., Doroshow, J. H., Synold, T., Lim, D., Shibata, S., Margolin, K., Schwarz, R., Leong, L., Somlo, G., Twardowski, P., Yen, Y., Chow, W., Lin, P., Paz, B., Chu, D., Frankel, P., Stalter, S. (2003) Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics. Clin. Cancer Res. 9: 5896-5901
13. Oku, M., Noda, T., Kiyozuka, Y., Ninomiya, Y., Hino, K., Okamura, Y., Maruyama, M., Ichijo, M. (1988) Pharmacokinetic analysis of intraperitoneal cisplatinum administration. Nippon Gan Chiryo Gakkai Shi. 23: 657-664
14. van Oosterom, A. T. (1999) Docetaxel (Taxotere) and gemcitabine phase I and early phase II studies: results to date and an overview of ongoing studies. Semin. Oncol. 26: 8-11
15. van Tellingen, O., Beijnen, J. H., Verweij, J., Scherrenburg, E. J., Nooijen, W. J., Sparreboom, A. (1999) Rapid esterase-sensitive breakdown of Polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice. Clin. Cancer Res. 5: 2918-2924
16. Yonemura, Y., Endou, Y., Bando, E., Kuno, K., Kawamura, T., Kimura, M., Shimada, T., Miyamoto, K., Sasaki, T., Sugarbaker, P. H. (2004) Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer. Cancer Lett. 210: 189-196